RER. Scott Evans

R. Scott Evans

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


R. Scott Evans has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rapid Identification of Hospitalized Patients at High Risk for MRSA Carriage

    by R. S. Evans, C. J. Wallace, J. F. Lloyd, C. W. Taylor, R. H. Abouzelof, S. Sumner, K. V. Johnson, A. Wuthrich, S. Harbarth, M. H. Samore, et al.

    Patients who are asymptomatic carriers of methicillin-resistant Staphylococcus aureus (MRSA) are major reservoirs for transmission of MRSA to other patients. Medical personnel are usually not aware when these high-risk patients are hospitalized. We developed and tested an enterprise-wide electronic surveillance system to identify patients at high risk for MRSA carriage at hospital admission and during hospitalization. During a two-month study, nasal swabs from 153 high-risk patients were tested for MRSA carriage using polymerase chain reaction (PCR) of which 31 (20.3%) were positive compared to 12 of 293 (4.1%, p < 0.001) low-risk patients. The mean interval from admission to availability of PCR test results was 19.2 hours. Computer alerts for patients at high-risk of MRSA carriage were found to be reliable, timely and offer the potential to replace testing all patients. Previous MRSA colonization was the best predictor but other risk factors were needed to increase the sensitivity of the algorithm.


  • Risk Factors for Adverse Drug Events: A 10-Year Analysis

    by R Scott Evans, James F Lloyd, Gregory J Stoddard, Jonathan R Nebeker, Matthew H Samore

    BACKGROUND: Many adverse drug events (ADEs) are the result of known pharmacologic properties, and some result from medication errors. However, some are the result of patient-specific risk factors. OBJECTIVE: To identify inpatient risk factors for ADEs. METHODS: Conditional logistic regression was used to analyze all pharmacist-verified ADEs by therapeutic class of drugs and severity during a 10-year study period. All inpatients ≥18 years of age from a 520-bed tertiary teaching hospital were included. Each case patient was matched with up to 16 control patients. Odds ratios for patient factors associated with ADEs were calculated from different therapeutic classes of drugs. RESULTS: Odds ratios for numerous risk factors were identified for 4376 ADEs and were found to vary depending on therapeutic classification. The risk factors for the different classifications were grouped by (1) patient characteristics—female (OR 1.5–1.7), age (0.7–0.9), weight (1.2–1.4), creatinine clearance (0.8–4.7), and number of comorbidities (1.1–12.6); (2) drug administration—dosage (1.2–3.7), administration route (1.4–149.9), and number of concomitant drugs (1.2–2.4); and (3) patient type—service (1.2–4.9), nursing division (1.5–3.8), and diagnosis-related group (1.5–5.7). CONCLUSIONS: Some risk factors are consistent for all ADEs and across multiple therapeutic classes of drugs, while others are class specific. High-risk agents should be closely monitored based on patient characteristics (gender, age, weight, creatinine clearance, number of comorbidities) and drug administration (dosage, administration route, number of concomitant drugs).


  • Evaluation of a Computer-Assisted Antibiotic-Dose Monitor

    by R Scott Evans, Stanley L Pestotnik, David C Classen, John P Burke

    OBJECTIVE: To examine the effect of a computer-assisted antibiotic-dose monitor used to reduce the number of days that patients receive excessive dosages of antibiotics and the number of adverse drug events (ADEs) secondary to antibiotics. DESIGN: Descriptive epidemiologic study of a two-year preintervention period and one-year intervention period. SETTING: The LDS Hospital, a tertiary care center in Salt Lake City, UT. PATIENTS: All patients aged • 18 years, admitted to LDS Hospital from April 1, 1993, to March 31, 1996, who received at least one of five targeted antibiotics (vancomycin, gentamicin, imipenem, cefazolin, cefuroxime), who had a serum creatinine or a urine creatinine clearance test result before antibiotic therapy, and who were never admitted or transferred to the shock/trauma/respiratory intensive care unit. METHODS: Each morning during the 12-month intervention period, the antibiotic-dose monitor checked the renal function of all patients who were receiving any of the five antibiotics. Pharmacists received a computer listing of patients who may have been receiving excessive dosages. The antibiotic-dose monitor suggested an alternate dosage and a pharmacikst contacted the patient's physician if the suggested change in the dosage was appropriate. RESULTS: During the intervention period, 4483 patients received at least one of the five study antibiotics and 1974 (44%) were identified as receiving an excessive dosage, compared with 4494 (50%) of 8901 patients during the preintervention period (p < 0.001). The patients receiving excessive dosages received an excessive dosage for an average of 2.9 days during the intervention period, compared with 4.7 days (p < 0.001) during the preintervention period. In addition, these same patients during the intervention period received fewer doses of antibiotics (10.9 vs. 13.4; p < 0.001), fewer grams of antibiotics (10.4 vs. 12.0; p < 0.02), at less cost ($98 vs. $128; p < 0.004) than the patients during the preintervention period. Moreover, there were 14 ADEs (0.3%) secondary to the five study antibiotics during the intervention period, compared with 82 (0.9%; p < 0.001) for the two-year preintervention period. The study also found that significantly more patients identified as receiving excessive dosages had experienced decreases in renal function, compared with patients who were not identified as receiving excessive dosages (25% vs. 12% during preintervention period and 23% vs. 16% during intervention period; p < 0.001). CONCLUSIONS: Many patients experience decreases in renal function after antibiotics are ordered. The use of the computer-assisted antibiotic-dose monitor appears to be a promising method to help reduce the excessive use and cost of antibiotic therapy and reduce the number of ADEs secondary to antibiotics.


  • Applications of Medical Informatics in Antibiotic Therapy

    by R. Scott Evans, Stanley L. Pestotnik

    Effective antibiotic therapy is an essential part of hospital care.1–3 Studies show that patients with rapidly fatal and ultimately fatal underlying diseases have improved chances for survival with appropriate antimicrobial therapy.4 However, several studies show that there is considerable overuse and misuse of antibiotics.5–8 Up to two thirds of hospitalized patients who receive antibiotics have no evidence of infection. The major cause for antibiotic overuse results from unnecessary or prolonged surgical prophylaxis. Studies also show that antibiotic prophylaxis should be initiated before the operation to be beneficial.9,10 Yet, many patients who would benefit from antibiotic prophylaxis do not receive the antibiotics until after the start of the operation.11,12 The selection of therapeutic antibiotics has been found to be inconsistent with microbiology data.13,14 This usually results from physicians being unaware of relevant susceptibility results. One study found that the selection of empiric antibiotics was unacceptable 34 percent of the time.15 The physicians were misinformed about likely pathogens and/or antibiotic susceptibilities. Organisms that were susceptible to antibiotics only a few years ago are now resistant.16 Antimicrobial resistance is spawned by the overuse and misuse of antibiotics. Keywords Adverse Drug Event Clinical Pharmacist Hospital Information System Medical Informatics Microbiology Culture These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


    • 1 January 1993
      • Vol. 10  (1) , 17-22

    Development of an automated antibiotic consultant.

    by R S Evans, S L Pestotnik, D C Classen, J P Burke

    Physicians frequently need to order antibiotic therapy before the results of bacterial cultures and antibiotic susceptibility tests are available. Therapy selected empirically should be chosen on the basis of the most recent information about probable pathogens and their susceptibility to various drugs. We have developed a series of computer programs to help physicians identify the antibiotic regimens with the highest probability of acting against the pathogens that are most likely to be present at suspected sites of infection in individual patients. This automated antibiotic consultant is now available on our hospital information system. A comparison of the antibiotic regimens suggested by the computer with those indicated by cultures and susceptibility tests showed that the computer suggested an appropriate regimen for 717 of 761 culture events (94%).


    • 1 September 1992
      • Vol. 27  (9) , 774, 776-9, 783

    Description of a computerized adverse drug event monitor using a hospital information system.

    by D C Classen, S L Pestotnik, R S Evans, J P Burke

    To improve the detection and characterization of adverse drug events (ADEs) in hospitalized patients, a computerized adverse drug event monitor was developed. Computer programs were written to allow for voluntary as well as automated detection of adverse drug events using the HELP hospital information system, a large integrated hospital database containing computerized patient medical records and a knowledge base allowing for automated medical decisions. Programs were created to allow simple computer entry of potential adverse drug events by physicians, pharmacists, and nurses. Automated detection of potential adverse drug events relied on signals such as sudden medication stop orders, "antidote" orders, and selected abnormal laboratory values. Each day a list of all potential adverse drug events from these sources was generated and a pharmacist reviewed the medical records and interviewed healthcare personnel associated with patients identified as having potential adverse drug events. This process allowed for characterization of the event, causality assessment, and follow-up of the resulting clinical course by the pharmacist. The permanent storage of these results in the computerized patient medical record permits their future retrieval to prevent adverse drug events during subsequent hospital care. The authors conclude that fully integrated hospital systems will permit the further development and evaluation of computer-assisted methods for the detection of adverse drug events in hospitalized patients.